111 studies found for:    "Measles"
Show Display Options
Download search resultsDownload the search results for:
"Measles" (111 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Prophylactic Antibiotics in Measles
Conditions: Post-Measles Pneumonia;   Measles
Intervention: Drug: Sulfamethoxazole-Trimethoprim
2 Completed Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
Conditions: Rubella;   Varicella;   Mumps;   Measles;   Measles-Mumps-Rubella-Varicella Vaccine
Interventions: Biological: PriorixTM;   Biological: VarilrixTM;   Biological: GSK Biologicals' vaccine 208136
3 Completed Impact of HIV on Measles and Measles Immunisation
Conditions: HIV Infection;   Measles;   Children
Intervention: Biological: standard-titer measles vaccine
4 Unknown  Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Measles
Intervention: Biological: attenuated measles vaccine
5 Completed Long-term Follow-up of Measles Antibodies
Condition: Measles
Intervention: Biological: Measles vaccine
6 Completed A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)
Condition: Measles
Interventions: Biological: V205C, measles, mumps, and rubella virus vaccine live;   Biological: Comparator: Measles, Mumps, and Rubella Virus Vaccine Live
7 Recruiting Additional Measles Vaccine at 4 Months of Age
Condition: Measles Infection
Intervention: Biological: Measles vaccine
8 Completed Early Two-dose Measles Vaccination Trial
Condition: Measles
Intervention: Biological: Measles vaccine
9 Unknown  Immunity to Measles Virus in the Thai Population Age 18-30 Years and Predictive Factors
Condition: Measles
Intervention:
10 Completed Non-Specific Effects of Standard Titre Measles Vaccination
Condition: Measles
Intervention: Biological: Measles and inactivated polio vaccine
11 Completed A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
Conditions: HIV Infections;   Measles
Interventions: Biological: Attenuvax;   Biological: M-M-R-II
12 Recruiting Early Waning of Maternal Measles and Meningitis C Antibodies
Condition: Measles
Intervention:
13 Recruiting Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients
Condition: Measles
Intervention: Biological: MMR vaccination
14 Not yet recruiting Study, to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella
Conditions: Rubella;   Measles
Intervention: Biological: Double viral (MR) vaccine
15 Recruiting Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR Vaccine
16 Completed
Has Results
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
17 Completed Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Priorix™;   Biological: Varilrix™
18 Completed Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
Condition: Measles
Interventions: Biological: MVA-mBN85B;   Biological: Rouvax
19 Recruiting Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine
20 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Conditions: Rubella;   Mumps;   Measles
Interventions: Biological: Priorix®;   Biological: Merck's M-M-R®II, Measles, Mumps, and Rubella Virus Vaccine (also known as M-M-R Vax Pro™);   Biological: Kinrix®;   Biological: Varivax®

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years